artesunic acid has been researched along with Liver Diseases in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Abdallah, DM; El-Abhar, HS; Ghoneim, ME; Shebl, AM | 1 |
Aweeka, FT; Charlebois, E; Coates, C; Dorsey, G; German, P; Greenhouse, B; Havlir, D; Lindegardh, N; Rosenthal, PJ | 1 |
2 other study(ies) available for artesunic acid and Liver Diseases
Article | Year |
---|---|
The interrupted cross-talk of inflammatory and oxidative stress trajectories signifies the effect of artesunate against hepatic ischemia/reperfusion-induced inflammasomopathy.
Topics: Animals; Apoptosis; Artesunate; Cytokines; Inflammasomes; Inflammation; Liver; Liver Diseases; Male; Oxidative Stress; Rats; Rats, Wistar; Reperfusion Injury; Signal Transduction | 2020 |
Hepatotoxicity due to a drug interaction between amodiaquine plus artesunate and efavirenz.
Topics: Adult; Alkynes; Amodiaquine; Artemisinins; Artesunate; Benzoxazines; Chemical and Drug Induced Liver Injury; Cohort Studies; Cyclopropanes; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Female; Humans; Liver Diseases; Liver Function Tests; Male; Middle Aged; Oxazines; Reference Values; Risk Assessment; Sesquiterpenes; Transaminases | 2007 |